Only sparse data on the outcomes of surgical AVR in nonagenarians are reported. From 2002 to 2011, a total of 16,911 open aortic valve procedures were performed in Sweden. Only 13 of these individuals (0.8%) were nonagenarians (Swedeheart Registry, http://www.ucr.uu.se/ swedeheart/index.php/arsrapporter). None of these individuals died within 30 days, although one each had died by 1, 2, and 6 years after surgery.A recent study reported on the feasibility of TAVI in a group of 26 nonagenarians using the CoreValve and the SAPIEN valve (Edwards Lifesciences, Irvine, CA). 8 The procedural success rate was 96%, whereas 19% of participants had major vascular complications, which were four times as common as in the control group of participants, who were younger than 90. Thirty-day, 6-month, and 1-year mortality were 15%, 27%, and 32.5%, respectively, versus 6%, 14%, and 22.4% in the control group.The results of the current study provide further evidence of the feasibility and safety of TAVI in carefully selected nonagenarians and compare well with those of TAVI in younger participants in previous studies. 7,9,10 Although further studies are warranted, the current study indicates that older age should not be a sole reason to exclude individuals from undergoing TAVI.Limitations of this retrospective study were that it was a single-center study of few individuals without a comparative group and that measurements of quality of life and physical capacity were not included.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.